Pediatric Critical Care Lidocaine Dosing
For pediatric critical care, use a loading dose of 1.5 mg/kg infused over 10 minutes, followed by a continuous infusion of 1.5 mg/kg/hour, with the infusion not exceeding 24 hours in most cases.
Loading Dose Protocol
The initial loading dose should be 1.5 mg/kg administered over 10 minutes 1. This slower infusion rate is critical—rapid bolus administration significantly increases toxicity risk. The loading dose must be given with an anesthetist or intensivist present, with continuous ECG monitoring, pulse oximetry, and blood pressure checks every 5 minutes during the initial infusion and for 15 minutes thereafter 1.
Important caveat: The FDA label indicates maximum pediatric dosing should not exceed 4.5 mg/kg (2 mg/lb) total dose without epinephrine, with an absolute maximum of 300 mg 2. For children under 10 years, Clark's rule may be applied—for example, a 5-year-old weighing 50 lbs should not exceed 75-100 mg total 2.
Maintenance Infusion
After the loading dose, initiate a continuous infusion at 1.5 mg/kg/hour 1. This rate typically maintains plasma concentrations below 5 μg/mL, which is below the toxic threshold. The practical advantage of using 1.5 mg/kg for both loading and maintenance dosing is numerical simplicity, reducing medication errors.
Duration and Monitoring
- Standard duration: 24 hours maximum 1
- If extension beyond 24 hours is necessary (e.g., chronic pain patients), reduce the infusion rate to 50% and obtain consultant approval 1
- Most postoperative pain decreases sufficiently within 24 hours to transition to other analgesics
Critical Monitoring Requirements
Location and Frequency
- Patients must be in a monitored bed space (HDU/level 2 care) outside the operating theater 1
- Observations every 15 minutes for the first hour, then hourly minimum 1
- Continuous ECG monitoring throughout infusion 1
Early Toxicity Signs (Neurological—appear FIRST)
- Peri-oral tingling
- Tinnitus
- Light-headedness
- Restlessness
- Note: Cardiovascular signs and ECG changes are LATE manifestations 1
Equipment Requirements
- Lipid emulsion 20% must be immediately available 1
- Dedicated, labeled, lockable infusion pump with anti-siphon mechanisms 1
- Separate dedicated IV line with one-way valve 1
- Minimum 10 mL/hour sodium chloride 0.9% flush through the same line 1
Concentration and Preparation
Use standardized hospital-wide concentration (typically 2% lidocaine = 20 mg/mL) 1. Commercially prepared syringes or bags reduce concentration errors and should be used when available 1.
Special Pediatric Considerations
Age-Specific Concerns
Neonates and preterm infants show significantly higher plasma lidocaine levels at standard dosing 3. In a study of neonatal seizures, preterm infants consistently achieved plasma concentrations >9 mg/L (the adult cardiac toxicity threshold) with standard dosing 3. While a modified regimen (2 mg/kg load, then 6 mg/kg/hour for 6 hours, 4 mg/kg/hour for 12 hours, 2 mg/kg/hour for 12 hours) showed 78% efficacy in term infants, optimal dosing for preterm infants remains undetermined 3.
Infants under 18 months achieve higher peak plasma levels, particularly with body weights <10 kg 4. There is a significant relationship between younger age and elevated plasma concentrations (p=0.00973) 4.
Adolescents and Older Children
For status migraine in children aged 10-19 years, a bolus of approximately 2.9 mg/kg followed by infusion starting at 1.29 mg/kg/hour (maximum 2.25 mg/kg/hour) demonstrated 90.3% pain resolution with minimal side effects 5. However, 51.6% experienced pain relapse, suggesting the need for transition planning 5.
Common Pitfalls to Avoid
- Rapid bolus administration: Always infuse loading dose over 10 minutes minimum 1
- Inadequate monitoring location: Do not manage these patients on general wards 1
- Missing early neurological signs: Train staff that CNS symptoms precede cardiac toxicity 1
- Concurrent lidocaine from other sources: Account for total lidocaine dose from all formulations (topical, regional blocks) 2
- Methemoglobinemia risk: Infants under 6 months are particularly susceptible; watch for cyanotic discoloration 2
Contraindications and Extreme Caution
Use extreme caution or avoid in:
- Sepsis or severely traumatized mucosa (rapid systemic absorption risk) 2
- Glucose-6-phosphate dehydrogenase deficiency (methemoglobinemia risk) 2
- Cardiac or pulmonary compromise 2
- Concurrent use with other oxidizing agents 2
Efficacy Context
While the evidence base in pediatrics is limited compared to adults 6, available data suggests perioperative IV lidocaine is well-tolerated and beneficial for reducing opioid requirements and improving recovery parameters in selected pediatric surgical patients 6. The 2021 international consensus statement provides the most comprehensive safety framework, though it was developed primarily from adult data 1.